期刊文献+

中西医结合治疗多囊卵巢综合征的临床观察 被引量:10

Clinical Research on Combined Therapy of Traditional Chinese and Western medicine on Polycystic Ovarian Syndrome
下载PDF
导出
摘要 目的:观察达因-35联合自拟调经汤治疗多囊卵巢综合征的临床疗效。方法:选择本院门诊60例多囊卵巢综合征患者,随机分为两组,即中西医结合治疗组:达英-35联合自拟调经汤,西药组:达英-35,每组各30例,观察治疗前及治疗中3个月、6个月以及停药后3个月检测血清:LH(黄体生成激素)、T(睾酮);并观察停药后3个月、6个月的月经情况、卵泡发育情况。结果:(1)停药3个月以及停药6个月后中西医结合组正常月经人数以及排卵人数多于西药组的人数(P<0.05)。(2)实验室指标检测表明:两组治疗中3个周期以及6个周期,停药3数个月以及6个月后较治疗前血清LH、T显著下降(P<0.001);且两组间相比西药组激素回升的机率比中西结合组的大(P<0.001)。结论:中西医结合治疗多囊卵巢综合征疗效更快,更稳定,更持久。 Objective:To observe Diane-35 joint the self-made tiao jing tang for polycystic ovarian syndrome and preliminary clinical efficacy of the mechanism.Methods:60 PCOS women were enrolled into study,they were divided into two groups randomly:group traditional Chinese and Western medicine was given Diane-35and self-made tiaojing tang,Western medicine treatment group which group only with taking Diane-35,each of them contained 30 cases.The sex hormones in serum LH (luteinzing hormone),T(testosterone) were tested 3 and 6 months after and before treatment.The Menstrual cases and the Follicular development situation were noted down 3 and 6 months after treatment.Results:(1)Found by clinical observation:Two groups before and after treatment with 6 months the clinical symptoms observed points of comparison,the two groups are able to adjust the menstrual cycle(P〈 0.05),traditional Chinese and Western combined treatment group than the other group(P〈0.05).(2)Laboratory testing showed that:Two groups of three treatment cycles and six cycles than pre-treatment serum LH,T decreased significantly(P〈0.001);after stopped the medicine for three months six months,Chinese and Western combined medicine group and the western medicine group of the blood serum of LH、T level still has the drop(P〈0.001).Conclusion:Traditional Chinese and Western medicine treatment of polycystic ovary syndrome combined with faster,more stable and more durable.
出处 《辽宁中医杂志》 CAS 北大核心 2010年第7期1328-1330,共3页 Liaoning Journal of Traditional Chinese Medicine
关键词 多囊卵巢综合征 黄体生成激素 睾酮 达因-35 自拟调经汤 polycystic ovarian syndrome LH T Diane-35 Self-made tiao jing tang
  • 相关文献

参考文献5

二级参考文献21

  • 1Fauser BCJ.Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod,2004,19(1): 41-47
  • 2Teede HJ, Meyer C, Norman RJ. Insulin-sensitisers in the treatment of polycystic ovary Syndrome. Expert Opin Pharmacother, 2005,6(14):2419-2427
  • 3Baillargeon JP, Nestler JE. Polycystic ovary syndrome: a syndrome of ovarian hypersensity to insulin? Clin Endocrinol Metab,2005,10(1):1804
  • 4Silfen ME, Manibo AM.Elevated free IGF-I levels in prepubertal hispanic girls with premature adrenarehe: relationship with hyperandregenism and insulin sensitivity. Clin Endocrinol Metab,2002, 87(1):398-403
  • 5Kolodziejczyk B, Duleha AJ. Metforrnin therapy decreases hyperan drogenism and hyperinsulinemia in women with polycystic ovary syndrome.Fertil Steril.2000,73(6): 1149-1154
  • 6Munir I, Yen HW. Insulin augmentation of 17-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells.Endocrinology,2004,145( 1):175-183
  • 7Martens JWM, Geller DH,Arlt W. Enzymatic activities of P450c17 stably expressed in fibroblasta from patients with the polycystic ovary syndrome.Clin Endocrinol Metab,2000,85(11):4338-4346
  • 8Shobokshi A, Shaarawy M. Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy. Soc Gynecol Investig,2003,10(2):99-104
  • 9Belli SH, Graffigna MN. Effect of rosiglitazone on insulin resistance,growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertil Steril,2004,81(3):624-629
  • 10Mitchell M, Armstrong DT. Adipokines: implications for female fertility and obesity. Reproduction,2005,1(30):583-597

共引文献46

同被引文献165

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部